The global cytomegalovirus (CMV) treatment market is experiencing steady growth, primarily driven by the rising prevalence of CMV infections among immunocompromised populations, including transplant recipients and individuals living with HIV. Increasing demand for effective antiviral therapies, along with advancements in diagnostic technologies, is playing a crucial role in...